CCRL2 and glioblastoma: Furthermore, in all types tested, i.e., oligodendroglioma WHO grade II, anaplastic oligoastrocytoma WHO grade III, and glioblastoma WHO grade IV, expression level of CCRL2 correlated significantly in a similar way with the expression of its potential ligands, CCL2 and CCL5.